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a  b  s  t  r  a  c  t
Previously,  we  have  demonstrated  the  analgesic-like  property  of p-cymene  in  rodents.  Short  half-life  is
a limitation  for  p-cymene  application  and  several  approaches  have  been  used  to improve  pharmaceu-
tical  properties  of  monoterpenes,  including  the  employment  of  drug-delivery  systems.  Here,  we used
p-cymene/-cyclodextrin  (-CD)  complex  and  p-cymene  (PC)  isolated  to  evaluated  whether  the  com-
plex  formulation  is  able  to  improve  the  antinociceptive  activity  of  this  monoterpene.  Male  mice (26–30  g)
were  pretreated  with  PC/-CD  (20  or 40 mg/kg,  p.o.),  PC (20  or 40  mg/kg,  p.o.)  or vehicle  (distilled  water),
0.5 h before  painful  tests  and  antinociceptive  effect  was  evaluated  at times:  0.5,  1, 2, 4,  8, and  16  h after
treatment.  We  evaluated  the  analgesic-like  effect  of  PC/-CD  and  PC  in acetic  acid-induced  abdominal
writhes,  hot-plate,  carrageenan-induced  paw  edema  and  in  rota-rod  apparatus.  Our  results  demonstrated
that  acute  treatment  with  complex  PC/-CD  produced  an  antinocicepitve  effect  (p  < 0.01  or p <  0.001)  for
8 h  followed  whereas  isolated  PC produced  the  same  effect  for  2 h. Similar  results  were  obtained  in hot-
plate  test,  PC/-CD,  in  all doses,  signiﬁcantly  reduces  (p  < 0.01  or p  <  0.001)  nociceptive  behavior  for  8 h
while  isolated  PC for 1  h,  did  so  only  in  higher  dose.  Such  results  were  unlikely  to  be  caused  by  motor
abnormality.  Systemic  pretreatment  with  PC/-CD  and  PC inhibited  the  development  paw  edema  by
carrageenan  1%,  but  PC/-CD  did  so  during  a longer  period  when  compared  with  isolated  monoterpene
alone.  Our  results  provide  evidence  to  propose  that  the complex  with  -CD  improved  analgesic  and
anti-inﬂammatory  effects  of  p-cymene.ntroduction
Monoterpenes, belonging to a large and diverse group of
hemical compounds termed ‘terpenes’, represent a group of
aturally-occurring organic compounds whose basic structure
onsists of two linked isoprene units, which are formed by 5-
arbon-base (C5) each. They are the most representative molecules
onstituting 90% of the essential oils and have a great variety
f structures (Bakkali et al. 2008). Monoterpenes are the major
hemical constituents of the essential oils obtained from medicinal
lants having therapeutic properties, mainly antioxidant, analgesic
nd anti-inﬂammatory (De Sousa 2011; Guimarães et al. 2013).
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Recently, some works have been demonstrated antinociceptive
and anti-inﬂammatory properties of monoterpenes, such as /-
pinene, carvacrol, -terpineol, and citronellol (Liapi et al. 2007;
Guimarães et al. 2013; Brito et al. 2012).
p-Cymene (p-isopropyltoluene) is a naturally-occurring aro-
matic organic compound (Santana et al. 2011). It is classiﬁed as
a hydrocarbon related to a monoterpene and it is a precursor of
carvacrol and one of the main constituents of the essential oil
from species of Protium, with more than 80% of these species
found in the Amazon region (Siani et al. 1999). p-Cymene is
present in volatile oils from over 100 plants and occurs naturally
in more than 200 foods (orange juice, grape fruit, tangerine, car-
rots, raspberries, butter, nutmeg, oregano, and almost every spice).
p-Cymene is an important intermediate used in pharmaceutical
industries and for the production of fungicides, pesticides, as ﬂavor-
Open access under the Elsevier OA license.ing agent (Selvaraj et al. 2002). Previous studies conducted by our
group demonstrated that p-cymene was able to present analgesic
and anti-inﬂammatory properties in mice (Santana et al. 2011;























































mJ. de Souza Siqueira Quintans et a
s a limitation for p-cymene or other monoterpene applications.
everal approaches have been used to improve pharmaceutical
roperties of monoterpenes, including the employment of drug-
elivery systems (Mourtzinos et al. 2008; Seraﬁni et al. 2012;
enezes et al. 2012).
Cyclodextrins (CDs) is one of several technologies available to
mprove the solubility of poorly water-soluble drugs. The most
emarkable property of CDs is their ability to modify the phys-
cochemical characteristics of molecules that are accommodated
ithin their internal cavity to form the so-called inclusion com-
lexes (Loftsson and Brewster 1997; Marreto et al. 2008). CD can
ncrease the aqueous solubility, chemical reactivity, and spectral
roperties of numerous lipophilic drugs which are used as guest
olecules, without changing their intrinsic ability to permeate
ipophilic membranes. Amidst these host molecules, -CD (beta-
yclodextrin) is widely employed to enhance the solubility, stability
nd bioavailability of drugs and is the preferred agent for encap-
ulation of drugs in the pharmaceutical industry (Seraﬁni et al.
012; Menezes et al. 2012). Additionally, some works have reported
hat the inclusion complex formation may  prolong and increase
he duration and intensity of drugs (Franco de Lima et al. 2012;
emelbekov et al. 2010).
In the present work, we used p-cymene/-cyclodextrin (-CD)
omplex and p-cymene isolated to evaluate in nociceptive and
nﬂammatory animal protocols, and study whether the complex




Experiments were performed on male Swiss mice (26–30 g)
btained from the Animal Facilities of the Federal University
f Sergipe. Mice were housed in controlled-temperature rooms
22–25 ◦C), under a 12:12 h light–dark cycle, with access to water
nd food ad libitum until use. All behavioral tests were performed
etween 8:00 a.m. and 4:00 p.m., and animals were only used once.
xperimental protocols were approved by the Animal Care and
se Committee at UFS/Brazil (CEPA#19/11). Every effort was made
o minimize the number of animals used and any discomfort. All
ehavior experiments were performed under blind conditions to
void inﬂuences of the observer in results.
reparation of inclusion complex
Samples and preparation of inclusion complexes 1-methyl-4-
1-methylethyl)benzene or p-cymene was purchased from Sigma,
SA (99.7%). -Cyclodextrin (-CD, batch number 127K0753) was
btained from Sigma–Aldrich. Inclusion complexes were prepared
ccording to Seraﬁni et al. (2012).  p-Cymene/-CD was  carried
ut by homogenization of -CD (3.405 g) with water (1.2:4, v/w)
irectly in an agate mortar. In a second step, 402.6 mg  of p-cymene
1:1 molar guest:host ratio) were added to -CD paste under
onstant manual agitation. Then, the material was  dried at room
emperature (in a desiccator) till the formation of a glass ﬁlm, which
as removed by manual trituration and stored in airtight glass
ontainers. Physical-chemical characterization of the p-cymene/-
iclodextrin (p-cymene/-CD) complex was carried out beforehand
n accordance with Seraﬁni et al. (2012).
nalgesic protocolscetic acid-induced abdominal writhes
Abdominal writhes consisted of a contraction of the abdominal
uscle together with a stretching of the hind limbs, induced byytomedicine 20 (2013) 436– 440 437
oral route (p.o., per os, by gavage route) injection in mice of acetic
acid (0.65% solution, 0.1 ml/10 g), the nociceptive agent (Koster
et al. 1959). Mice (n = 8, per group) were pretreated with p-cymene
(40 mg/kg, p.o.), p-cymene/-CD (40 mg/kg, p.o.), or vehicle (dis-
tilled water) by p.o. route. Then, after 0.5, 1, 2, 4, 8 or 16 h the mice
received the acetic acid injection (i.p.). The abdominal writhes were
observed, in separate individual chambers, for a period of 20 min,
starting after the administration of acetic acid.
Hot-plate test
Mice (n = 8, per group) were pretreated with p-cymene (20 or
40 mg/kg, p.o.), p-cymene/-CD (20 or 40 mg/kg, p.o.), or vehicle
(distilled water) by p.o. route or morphine (MOR, 5 mg/kg, i.p.), and
after they were placed individually on a metallic plate warmed
to 55 ± 0.5 ◦C (n = 9/group) (Model EFF 361, Insight®, Ribeirão
Preto/SP/Brazil). The time elapsed until the appearance of reactions
(latency, in s) toward the thermal stimulus, such as lifting or licking
of the paws, was recorded as an index of nociception (Le Bars et al.
2001). Measurements were performed at times 0.5, 1, 2, 4, and 8 h
after the ﬁrst thermal stimulus. In order to avoid damage to the
animal’s paws, the maximal time standing on the plate was  limited
to 30 s.
Evaluation of the motor activity
A rota-rod apparatus (AVS®, Brazil) was  used to assess whether
the treatments with complex or isolated monoterpene could inﬂu-
ence the motor activity of the animals and consequently impair
the assessment of the nociceptive behavior in experimental mod-
els (Quintans-Júnior et al. 2010a).  The mice were pretrained in the
same rota-rod apparatus at a constant speed of 9 rpm once a day
for 2 days before the test. Those mice that were able to remain on
the rotating rod for 180 s were selected for the test. In our exper-
iments, all mice received the same pharmacological treatment as
previously described in acetic acid-induced abdominal writhes test.
Performance time was assessed as the time up to the three falls.
Anti-inﬂammatory protocol
Measurement of paw edema in mice
The anti-inﬂammatory activity was  studied using the paw
edema model induced by 1% carrageenan, administrated at volume
of 0.1 ml/animal into the subplantar region of the right hindpaw of
the rat (Winter et al. 1962). The volume of the paw was  measured
by the removal of the water column using a hydroplethysmometer
(model EFF 304, Insight®, Ribeirão Preto/SP/Brazil), at the time 0
and the intervals of 1, 2, 3, 4 and 8 h immediately after the subplan-
tar injection of carrageenan (Thomazzi et al. 2010).
The mice were pretreated with p-cymene (20 or 40 mg/kg,
p.o.), p-cymene/-CD (20 or 40 mg/kg, p.o.), or vehicle (dis-
tilled water) were administrated p.o. 1 h before the edematogenic
agent to different groups of animals for each treatment (n = 8/per
group). The data obtained for the various groups were reported as
means ± S.E.M. and expressed in milliliters (Thomazzi et al. 2010).
Statistical analysis
Data were evaluated using GraphPad Prism version 5.0 (Graph-
Pad Prism Software Inc., SanDiego, CA, USA), through analysis of
variance (ANOVA) followed by Tukey’s test. The results are pre-
sented as mean ± S.E.M. In all cases, the differences were considered
signiﬁcant if p < 0.05. The percentile of inhibition of edema vol-
ume  between treated and control groups was  calculated using
the following formula (Quintans-Júnior et al. 2010b): Inhibition
% = 100 × (Vc − Vt)/Vc. Where Vc and Vt represent mean increase
in paw volume in control and treated groups, respectively.
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Fig. 1. Time response curve for the antinociceptive effect of (A) p-cymene or (B) p-
cymene/-CD complex on acetic acid-induced writhing response in mice. Writhings
were counted over 20 min  following i.p. administration of acetic acid (0.65%). p-






















wefore acid acetic injection (0.65%). Control animals received a injection of vehicle
y p.o. route. Each column represents mean ± S.E.M. (n = 8, per group). * p < 0.05 or
*  p < 0.001 vs. control (ANOVA followed by Tukey’s test).
rugs and reagents
Tween 80, Indomethacin, -Carrageenan, p-Cymene (99%
urity) and -cyclodextrin (≥97% purity) were purchased from
igma–Aldrich (USA). Acetic acid was purchased from Vetec
Brazil).
To prepare the pharmacological solution with p-cymene/-CD
efore treatment, we used an approximately 1:1 Molar. Hence, as
he molecular mass of p-cymene is 134.22 g/mol and the molecu-
ar mass of -CD is 1134.98 g/mol, we used one reason 1:1 Molar.
hus, when we administrated p-cymene/-CD complex in mice,
his was done in nominal dose (i.e. 20 mg/kg of the p-cymene/-
D means that the dose used was of 20 mg/kg p-cymene). All drugs
ere administered in volumes of 0.1 ml/10 g (mice), according to
atista et al. (1995).
esults
The results in Fig. 1 demonstrate that p-cymene or p-cymene/-
D complex, in the same dose (40 mg/kg, p.o.) 0.5 h beforehand
aused a marked inhibition of nociceptive behavior (p < 0.05 or
 < 0.001) on acetic acid-induced writhes, and treatment with p-
ymene/-CD caused a signiﬁcant (p < 0.001) inhibition of writhes
uring the ﬁrst 8 h.
Table 1 shows the results of the hot plate test. Pretreatment
ith p-cymene or p-cymene/-CD complex signiﬁcantly (p < 0.05ytomedicine 20 (2013) 436– 440
or p < 0.001) increased the latency time (reaction time) to the ther-
mal  stimulus in both the licking and jump parameters evaluated.
The parameter of reaction time was  signiﬁcantly (p < 0.01) more
consistent and lasting in p-cymene/-CD complex group when
compared with p-cymene group, mainly in dose 40 mg/kg (p.o).
As expected, the treatment of mice with morphine (5 mg/kg, i.p.,
0.5 h beforehand) caused a marked increase in latency (p < 0.01 or
p < 0.001) at all analyzed periods according to assessment in the
hot-plate test.
At the Rota-rod test, p-cymene or p-cymene/-CD-treated mice
did not demonstrate any signiﬁcant motor performance changes
(Data not shown).
Anti-inﬂammatory effect of the p-cymene or p-cymene/-CD
complex (20 or 40 mg/kg, p.o.) was evaluated in the paw edema
model. As observed in Table 2, the single oral treatment of mice
with the p-cymene/-CD complex (40 mg/kg, p.o.), but not with
p-cymene, was  capable of reducing (p < 0.05) the edema forma-
tion induced by carrageenan (1%), an effect observed at 2, 3, and
4 h after the administration of this phlogistic agent. p-Cymene had
effectiveness (p < 0.05) only in higher dose during the ﬁrst 1 of eval-
uation. Likewise, indomethacin signiﬁcantly inhibited (p < 0.001)
the edematogenic response evoked by carrageenan in mice.
Discussion
Previous studies have demonstrated analgesic and anti-
inﬂammatory proﬁle of p-cymene, a monoterpene present in
volatile oils of medicinal plants (Santana et al. 2011; Bonjardim
et al. 2012). However, monotepenes have little solubility in water
and pharmacological properties have a short half-life, what limits
their use in painful and inﬂammatory conditions. Lately, the phar-
maceutical industry cyclodextrins (CDs) have mainly been used as
complexing agents to increase aqueous solubility of poorly sol-
uble drugs (as monoterpenes or essential oils), and to increase
their bioavailability and stability (Loftsson et al. 2005; Seraﬁni
et al. 2012; Menezes et al. 2012). Studies in both humans and ani-
mals have shown that cyclodextrins can be used to improve drug
delivery from almost any type of drug formulation (Tiwari et al.
2010). Thus, we study antinociceptive effect of p-cymene or p-
cymene/-CD complex through the acetic acid-induced abdominal
constriction and hot-plate tests, and anti-inﬂammatory property
through the carrageenan-induced paw edema in mice. We  evalu-
ate whether p-cymene/-CD complex improves pharmacological
proﬁle of p-cymene.
Acetic acid-induced abdominal constriction is a standard, sim-
ple and sensitive test for measuring analgesia induced by both
opioids and peripheral-action analgesics (Hunskaar & Hole 1987).
In acetic acid-induced abdominal writhing, pain is elicited by
the injection of an irritant such as acetic acid into the periton-
eal cavity which produces episodes of characteristic stretching
(writhing) movements, and inhibition of the number of episodes
by analgesics is easily quantiﬁable (Le Bars et al. 2001). More-
over, it is already well documented that the quantiﬁcation of
prostaglandins by radioimmunoassay in the peritoneal exudates of
rodents obtained after the i.p. administration of acetic acid demon-
strated high levels of prostaglandins PGE2 and PGF2 during 0.5 h
after stimulus (Deraedt et al. 1980). Our results demonstrated that
both p-cymene or p-cymene/-CD mice after oral administration
produced antinociceptive effect, but p-cymene/-CD induced a
lingering inhibition of nociceptive behavior for 8 straight hours.
Although this method presents a good sensitivity, it shows poor
speciﬁcity (Le Bars et al. 2001).
To evaluate whether analgesic proﬁle demonstrated by p-
cymene/-CD complex improves pharmacological property of
isolated compound, we  investigated it in hot-plate test in mice.
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Table 1
Effects of p-cymene, p-cymene/-CD or morphine on the hot plate test in mice.
Treatment Dose (mg/kg) Reaction time (s)a
Basal 0.5 h 1 h 2 h 4 h 8 h
Vehicle – 8.3 ± 2.1 10.5 ± 2.9 8.1 ± 3.5 8.9 ± 3.1 11.1 ± 4.2 9.9 ± 3.7
p-Cymene 20 9.5 ±  3.9 12.5 ± 3.1 14.0 ± 2.1b 15.6 ± 2.0b 13.5 ± 2.7 10.3 ± 2.2
p-Cymene 40 8.9 ± 3.1 12.1 ± 2.2 16.2 ± 3.2b 15.1 ± 2.5b 12.9 ± 1.9 13.4 ± 3.1
p-Cymene/-CD  20 11.2 ± 2.9 19.1 ± 3.2d 18.2 ± 2.9d 19.7 ± 4.4d 17.3 ± 4.1c 13.9 ± 5.3
p-Cymene/-CD  40 10.4 ± 3.1 17.4 ± 1.1d 22.3 ± 3.5d,e 23.4 ± 4.3d,e 18.3 ± 3.2d 16.7 ± 2.1b
Morphine 5 10.5 ± 4.2 21.9 ± 4.5d 27.3 ± 2.8d 25.5 ± 5.3d 23.9 ± 3.9d 17.9 ± 4.1c
n = 8, per group.
a Values represent mean ± S.E.M.
b p < 0.05.
c p < 0.01.
d p < 0.001 (one-way ANOVA and Tukey’s test), signiﬁcantly different from control group.
e p < 0.01 (one-way ANOVA and Tukey’s test), signiﬁcantly different from p-cymene (40 mg/kg, p.o.) treated group.
Table 2
Effect of p-cymene, p-cymene/-CD or indomethacin on carrageenan-induced hind paw edema in mice.
Treatment Dose (mg/kg) Mean ± S.E.M. (ml)a % Edema Inhibition
1 h 2 h 4 h 8 h
Vehicle – 0.23 ± 0.04 0.33 ± 0.03 0.32 ± 0.07 0.35 ± 0.04 –
p-Cymene 20 0.22 ± 0.04 0.28 ± 0.07 0.29 ± 0.09 0.32 ± 0.05 32.8
p-Cymene 40 0.14 ± 0.05b 0.29 ± 0.04 0.31 ± 0.05 0.32 ± 0.03 36.8
p-Cymene/-CD  20 0.19 ± 0.07 0.24 ± 0.05b 0.25 ± 0.07b 0.31 ± 0.09 42.5
p-Cymene/-CD  40 0.15 ± 0.03b 0.20 ± 0.03c 0.22 ± 0.02c 0.33 ± 0.06 49.8
Indomethacin 10 0.16 ± 0.04c 0.17 ± 0.04c 0.19 ± 0.03c 0.25 ± 0.05b 60.4
n = 8, per group.

































db p < 0.05 (one-way ANOVA and Tukey’s test), signiﬁcantly different from control
c p < 0.001 (one-way ANOVA and Tukey’s test), signiﬁcantly different from contro
ubstances and drugs that produce strong inhibitory effects in the
ot-plate test can inhibit centrally-induced pain and act as strong
nalgesics (Le Bars et al. 2001). The results demonstrated that p-
ymene or p-cymene/-CD-mice produced signiﬁcant reduction of
ociception behavior during the hot-plate test. Thoses effects cor-
oborate with those previously shown by Bonjardim et al. (2012);
owever, p-cymene/-CD complex produced a lasting analgesic
ffect for 8 h, with the higher dose, and induced a strongly analgesic
ffect (p < 0.01) when compared with p-cymene alone.
Several studies have reported that the use of drugs that produces
NS depression or the nonspeciﬁc muscle relaxation effect can
educe the response of motor coordination and might stultify the
ehavioral tests results (Almeida et al. 2004; De Sousa et al. 2006;
uintans-Júnior et al. 2010a).  Thus, present results demonstrated
hat all p-cymene or p-cymene/-CD-treated mice, in doses eval-
ated, did not have any performance alteration in the rota-rod
pparatus.
The initial phase of carrageenan paw edema is mediated by
istamine and serotonin, while the mediators in the later phase
ere suggested to be arachidonate metabolites (prostaglandins
nd leukotrienes) producing an edema dependent on the mobi-
ization of neutrophils (Vinegar et al. 1987; Hwang et al. 1996).
ur results demonstrated that edematous response was  signiﬁ-
antly suppressed in mice pre-treated with the p-cymene, in higher
ose, and p-cymene/-CD complex in the ﬁrst phase of the edema,
uggesting an inhibitory effect on the release of histamine and/or
erotonin. However, p-Cymene/-CD complex demonstrated a sig-
iﬁcant inhibition of the edema in the second and third phase of
dema, suggesting an inhibition of 5-lipoxygenase and/or cyclooxy-
enase, both enzymes involved in the formation of prostaglandins
nd leukotrienes. As expected, this edematous response was
lso reduced in mice pre-treated with indomethacin, a reference
rug..
p.
Therefore, a marked inhibition to mice edema induced by
carrageenan was found following oral administration of p-
cymene/-CD inclusion complex at tested doses and the inhibition
was  signiﬁcantly higher than those of the same amount of p-
cymene at early stage, indicating that the effect of inclusion
complexes group acted more rapidly and powerful in comparison
with that of monoterpene isolated (p-cymene).
Several studies have demonstrated that the inclusion in -
ciclodextrin improves the analgesic properties of the drugs like
nonsteroidal anti-inﬂammatory drug (NSAID) or analgesic drugs
(Lu et al. 2004; Franco de Lima et al. 2012). CD can form inclu-
sion complexes with lipophylic drugs that have physical, chemical,
and biological properties dramatically different from those of either
the parent drug/ligand or cyclodextrin. Such complexes are used to
enhance solubility and dissolution rate, lower volatility and alter
release rates, as well as to reduce local irritation and increase
the stability of drugs (Rajewskix and Stella 1996). To improve the
duration of action and improve pharmacological property, several
drug-carrier systems have been used, as cyclodextrins (Jug et al.
2010; Franco de Lima et al. 2012).
Thus, our results provide evidence to propose that complex with
-CD improved analgesic and anti-inﬂammatory effects of the p-
cymene. Further on-going studies will enable us to understand the
precise mechanisms whereby -CD complex improves bioavail-
ability of the drug and enhances the pharmacological effects.
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